GlaxoSmithKline RFID Pilot Project Update

As part of a pilot project to help protect patient safety, GlaxoSmithKline has begun distributing a medicine tagged with RFID. The tags will be placed on all bottles of Trizivir (an HIV medicine) distributed in the United States. When scanned at close range, the tags will help verify that the medicine bottle contains authentic Trizivir. This specific medicine was selected for the project because it has been listed by the National Association of Boards of Pharmacy as one of 32 drugs most susceptible to counterfeiting and diversion.

You can see the complete article here.